CRISPR Therapeutics AG (CRSP) Treasury Shares (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Treasury Shares of $60000.0 for Q1 2026, little changed sequentially from $60000.0 in Q4 2025, and down 3.23% YoY from $62000.0 in Q1 2025.
CRISPR Therapeutics AG (CRSP) Treasury Shares (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Treasury Shares for 10 years, with the latest figure at $60000.0 in Q1 2026.
- Quarterly Treasury Shares fell 3.23% year-over-year to $60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60000.0 (down 3.23% YoY) and the FY2025 annual result came in at $60000.0, down 3.23% from the prior year.
- Treasury Shares steadied at $60000.0 in Q1 2026 per CRSP's latest filing, from $60000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $21.0 million in Q2 2023 and troughed at $170316.0 in Q4 2023.
- A 5-year average of $5.7 million and a median of $2.0 million in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares changed 0.0% in 2022, then retreated 3.23% in 2025.
- Over 5 years, Treasury Shares stood at $63000.0 in 2022, then slipped by 1.59% to $62000.0 in 2023, then changed by 0.0% to $62000.0 in 2024, then dropped by 3.23% to $60000.0 in 2025, then changed by 0.0% to $60000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $60000.0, $60000.0, and $60000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.69 Mn |
| Jun 30, 2026 | 60,000.00 |
| Jun 30, 2026 | 60,000.00 |
| Jun 30, 2026 | 17.69 Mn |
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 17.69 Mn |
| Mar 31, 2026 | 17.69 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Sep 30, 2025 | 19.54 Mn |
| Sep 30, 2025 | 19.54 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 62,000.00 |